Skip to content

DR GIO

Active
Private limited companyfounded 20242 yrs activede Stassartstraat 88, 1050 Elsene, BelgiumKBO/BCE: BE 1010.298.649
Summary

The computed 12-month bankruptcy probability of DR GIO is 5.6% (elevated). The 2024 annual accounts show equity of €17,974 and a net result of €12,974. The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2024
59 / 100
Fair
An elevated bankruptcy probability caps the score. Every signal that weighs is under Signals.
Axes
Profitability100
Solvency100
Growth-
Track record67
Bankruptcy probability, 12 months
5.6% Elevated
0%0.5%1.5%4%10%≥ 25%
Credit up to €1,000 at 30 days only on tighter terms
Liquidity ample (current ratio 4.54; short-term debt: 17.7% and cash: 79.8% of total assets), and 17.7% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
82.3%
Return on assets
59.4%
Age of the figures
21 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 05-08-2025, 5 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2024
5 d late
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its 2024 accounts 5 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 12 June 2024, DR GIO was incorporated as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2024.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2024

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, micro schema

Equity
€17,974
Total assets
€21,849
Net result
€12,974
Working capital
€13,709

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €21,849
Fixed assets €4,266
Current assets €17,584
Equity and liabilities €21,849
Equity €17,974
Debt €3,875
Debt finances 17.7% of the balance-sheet total.
Key figures and ratios
2024 value
EBITDA
€17,269
Cash flow
€13,209
Current ratio
4.54
Debt to equity
0.22
ROE
72.2%
ROA
59.4%
Interest coverage
168.61
Debt ≤ 1 year
€3,875
Income taxes
€3,958
Annual accounts
Filed annual accounts As filed with the NBB · 2024 · 29 lines
Balance sheet Code2024
Assets
Total assets20/58€21,849
Fixed assets21/28€4,266
Tangible fixed assets22/27€4,266
Furniture and vehicles24€4,266
Current assets29/58€17,584
Cash at bank and in hand54/58€17,431
Deferred charges and accrued income490/1€153
Equity and liabilities
Total equity and liabilities10/49€21,849
Equity10/15€17,974
Contributions10/11€5,000
Reserves13€12,974
Distributable reserves133€12,974
Amounts payable17/49€3,875
Amounts payable within one year42/48€3,875
Taxes, remuneration and social security45€3,875
Taxes450/3€3,875
Income statement Code2024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€234
Other operating charges640/8€1,244
Gross operating margin9900€18,512
Operating profit (loss)9901€17,034
Financial charges65/66B€102
Recurring financial charges65€102
Profit (loss) for the period before taxes9903€16,932
Income taxes67/77€3,958
Profit (loss) for the period9904€12,974
Profit (loss) for the period to be appropriated9905€12,974
Appropriation of the result
Profit (loss) to be appropriated9906€12,974
Transfer to equity691/2€12,974
To the legal reserve6920€12,974

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€234
Other operating charges640/8€1,244
Gross operating margin9900€18,512
Operating profit (loss)9901€17,034
Financial charges65/66B€102
Recurring financial charges65€102
Profit (loss) for the period before taxes9903€16,932
Income taxes67/77€3,958
Profit (loss) for the period9904€12,974
Profit (loss) for the period to be appropriated9905€12,974
Line2024
Assets
Total assets20/58€21,849
Fixed assets21/28€4,266
Tangible fixed assets22/27€4,266
Furniture and vehicles24€4,266
Current assets29/58€17,584
Cash at bank and in hand54/58€17,431
Deferred charges and accrued income490/1€153
Equity and liabilities
Total equity and liabilities10/49€21,849
Equity10/15€17,974
Contributions10/11€5,000
Reserves13€12,974
Distributable reserves133€12,974
Amounts payable17/49€3,875
Amounts payable within one year42/48€3,875
Taxes, remuneration and social security45€3,875
Taxes450/3€3,875
Line2024
Profit (loss) for the period9904€12,974
+ Depreciation and write-downs630€234
Operating cash flow (approximation)€13,209

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2025
05-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 5 days late
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Elsene · 1 establishment unit since 2024
seat establishment The establishment unit on the map
Ground area
142 m²
Building footprint
84 m²
Volume, LiDAR
1,035 m³
Parcel 21009A0358/00V000, Brussels · tallest building 16.1 m, ±5 floors. Linked by address, not a title deed.
9 companies at this address See who is registered here
1 establishment unit
DR GIO
de Stassartstraat 88, 1050 ElseneSpecialist medical practice
since 20242.363.195.657
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21009A0358/00V000 Brussels 142 m² 1 · 84 m² 16.1 m · 5 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Identification & contact

Identification
Legal formPrivate limited company
Founded12-06-2024
Fiscal year end31-12

Scores and ratios are computed by Checked and are not a credit decision.